Payment overview · 2025
General Payments
$319,117.95
312 reported records · 22 companies
Healthcare provider profile · identity verified
Jad Georges Khalil, M.D.
Allopathic & Osteopathic Physicians|Orthopaedic Surgery · SOUTHFIELD, MI · NPI 1124237912
Verified facts
What the public records show
CMS Open Payments records show Jad Georges Khalil, M.D. received $319,117.95 in general payments during 2025 across 312 reported records.
Stryker Corporation accounted for 45.6% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 59 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Stryker Corporation | Unresolved — no canonical attribution shown | $145,532.90 | 45.6% | 101 | 2025 |
| Globus Medical, Inc. | Unresolved — no canonical attribution shown | $82,073.93 | 25.7% | 107 | 2025 |
| Orthofix Medical, Inc. | Unresolved — no canonical attribution shown | $45,011.51 | 14.1% | 36 | 2025 |
| SI-BONE, INC. | Unresolved — no canonical attribution shown | $33,891.75 | 10.6% | 27 | 2025 |
| Boston Scientific Corporation | Unresolved — no canonical attribution shown | $9,835.68 | 3.1% | 16 | 2025 |
| VB Spine LLC | Unresolved — no canonical attribution shown | $1,500.00 | 0.5% | 1 | 2025 |
| Medtronic, Inc. |
Medtronic, Inc. exact · evidence 2025-07-22 |
$283.01 | 0.1% | 3 | 2025 |
| Abbott Laboratories | Unresolved — no canonical attribution shown | $161.20 | 0.1% | 3 | 2025 |
| Highridge Medical LLC | Unresolved — no canonical attribution shown | $154.83 | 0.1% | 1 | 2025 |
| Cerapedics Inc. | Unresolved — no canonical attribution shown | $141.53 | 0.0% | 2 | 2025 |
| Centinel Spine, LLC | Unresolved — no canonical attribution shown | $124.47 | 0.0% | 1 | 2025 |
| OssDsign USA Incorporated | Unresolved — no canonical attribution shown | $85.92 | 0.0% | 1 | 2025 |
| Nalu Medical, Inc. | Unresolved — no canonical attribution shown | $64.67 | 0.0% | 2 | 2025 |
| Bioventus LLC | Unresolved — no canonical attribution shown | $55.98 | 0.0% | 2 | 2025 |
| Baxter Healthcare | Unresolved — no canonical attribution shown | $38.36 | 0.0% | 2 | 2025 |
| SPR Therapeutics, Inc | Unresolved — no canonical attribution shown | $37.90 | 0.0% | 1 | 2025 |
| Curonix LLC | Unresolved — no canonical attribution shown | $30.41 | 0.0% | 1 | 2025 |
| Kuros Biosciences USA, Inc | Unresolved — no canonical attribution shown | $24.33 | 0.0% | 1 | 2025 |
| Saluda Medical Americas, Inc. | Unresolved — no canonical attribution shown | $19.24 | 0.0% | 1 | 2025 |
| DePuy Synthes Sales Inc. | Unresolved — no canonical attribution shown | $18.25 | 0.0% | 1 | 2025 |
| Amgen Inc. | Unresolved — no canonical attribution shown | $17.68 | 0.0% | 1 | 2025 |
| Providence Medical Technology, Inc. | Unresolved — no canonical attribution shown | $14.40 | 0.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Consulting Fee | $235,402.50 | 68 |
| Travel and Lodging | $32,615.51 | 98 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $30,071.25 | 14 |
| Compensation for serving as faculty or as a speaker for a medical education program | $12,225.00 | 5 |
| Food and Beverage | $8,803.69 | 127 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| SPINEJACK Normalized: spinejack |
Device | Stryker Corporation | $70,332.80 | 37 | 2025 |
Source payment records
|
|||||
| Senza Normalized: senza |
Device | Globus Medical, Inc. | $43,904.49 | 52 | 2025 |
Source payment records
|
|||||
| OPTABLATE Normalized: optablate |
Device | Stryker Corporation | $38,452.10 | 32 | 2025 |
Source payment records
|
|||||
| IFUSE IMPLANT SYSTEM Normalized: ifuse implant system |
Device | SI-BONE, INC. | $33,611.38 | 21 | 2025 |
Source payment records
|
|||||
| MILD DEVICE KIT Normalized: mild device kit |
Device | Stryker Corporation | $31,920.83 | 21 | 2025 |
Source payment records
|
|||||
| MISCELLANEOUS Normalized: miscellaneous |
Device | Orthofix Medical, Inc. | $25,161.21 | 19 | 2025 |
Source payment records
|
|||||
| EXCELSIUS GPS Normalized: excelsius gps |
Device | Globus Medical, Inc. | $13,909.28 | 12 | 2025 |
Source payment records
|
|||||
| OMNICURVE Normalized: omnicurve |
Device | Stryker Corporation | $12,072.00 | 2 | 2025 |
Source payment records
|
|||||
| VERTAPLEX Normalized: vertaplex |
Device | Stryker Corporation | $9,375.00 | 5 | 2025 |
Source payment records
|
|||||
| RELINE Normalized: reline |
Device | Globus Medical, Inc. | $9,022.16 | 18 | 2025 |
Source payment records
|
|||||
| VYRSA V1 Normalized: vyrsa v1 |
Device | Globus Medical, Inc. | $6,444.04 | 7 | 2025 |
Source payment records
|
|||||
| Clinical Trial Product Normalized: clinical trial product |
Device | Boston Scientific Corporation | $6,057.83 | 4 | 2025 |
Source payment records
|
|||||
| SIMPLIFY CERVICAL ARTIFICIAL DISC Normalized: simplify cervical artificial disc |
Device | Globus Medical, Inc. | $4,616.27 | 5 | 2025 |
Source payment records
|
|||||
| Intracept Normalized: intracept |
Device | Boston Scientific Corporation | $3,665.74 | 11 | 2025 |
Source payment records
|
|||||
| AUGMENT INJECTABLE Normalized: augment injectable |
Device | Stryker Corporation | $1,995.87 | 7 | 2025 |
Source payment records
|
|||||
| Lattus Normalized: lattus |
Device | Orthofix Medical, Inc. | $1,886.25 | 10 | 2025 |
Source payment records
|
|||||
| N/A Normalized: n a |
Device | Stryker Corporation | $1,875.00 | 3 | 2025 |
Source payment records
|
|||||
| CASCADIA INTERBODY SYSTEM Normalized: cascadia interbody system |
Device | VB Spine LLC | $1,500.00 | 1 | 2025 |
Source payment records
|
|||||
| SPINEMAP Normalized: spinemap |
Device | Stryker Corporation | $1,500.00 | 2 | 2025 |
Source payment records
|
|||||
| XIA 3 Normalized: xia 3 |
Device | Stryker Corporation | $1,500.00 | 1 | 2025 |
Source payment records
|
|||||
| CAPTIVATE Normalized: captivate |
Device | Globus Medical, Inc. | $1,008.42 | 3 | 2025 |
Source payment records
|
|||||
| PCD Normalized: pcd |
Device | Stryker Corporation | $975.00 | 1 | 2025 |
Source payment records
|
|||||
| ES2 SPINAL SYSTEM Normalized: es2 spinal system |
Device | Stryker Corporation | $750.00 | 1 | 2025 |
Source payment records
|
|||||
| INDEPENDENCE Normalized: independence |
Device | Globus Medical, Inc. | $316.57 | 2 | 2025 |
Source payment records
|
|||||
| ACP Normalized: acp |
Device | Globus Medical, Inc. | $300.92 | 4 | 2025 |
Source payment records
|
|||||
| COHERE Normalized: cohere |
Device | Globus Medical, Inc. | $192.20 | 2 | 2025 |
Source payment records
|
|||||
| MODULUS Normalized: modulus |
Device | Globus Medical, Inc. | $192.20 | 2 | 2025 |
Source payment records
|
|||||
| CORRIDOR Normalized: corridor |
Device | Globus Medical, Inc. | $175.71 | 1 | 2025 |
Source payment records
|
|||||
| SABLE Normalized: sable |
Device | Globus Medical, Inc. | $165.56 | 2 | 2025 |
Source payment records
|
|||||
| Mariner Normalized: mariner |
Device | Orthofix Medical, Inc. | $162.22 | 1 | 2025 |
Source payment records
|
|||||
| PROCLAIM Normalized: proclaim |
Device | Abbott Laboratories | $161.20 | 3 | 2025 |
Source payment records
|
|||||
| MOBI-C PLUG & FIT US Normalized: mobi c plug fit us |
Device | Highridge Medical LLC | $154.83 | 1 | 2025 |
Source payment records
|
|||||
| INTELLIS ADAPTIVESTIM Normalized: intellis adaptivestim |
Device | Medtronic, Inc. | $143.78 | 1 | 2025 |
Source payment records
|
|||||
| I-FACTOR PEPTIDE ENHANCED BONE GRAFT Normalized: i factor peptide enhanced bone graft |
Device | Cerapedics Inc. | $141.53 | 2 | 2025 |
Source payment records
|
|||||
| MAZOR X SYSTEM Normalized: mazor x system |
Device | Medtronic, Inc. | $125.61 | 1 | 2025 |
Source payment records
|
|||||
| PRODISC L Normalized: prodisc l |
Device | Centinel Spine, LLC | $124.47 | 1 | 2025 |
Source payment records
|
|||||
| 7D Surgical System Normalized: 7d surgical system |
Device | Orthofix Medical, Inc. | $121.83 | 2 | 2025 |
Source payment records
|
|||||
| CREO Normalized: creo |
Device | Globus Medical, Inc. | $114.94 | 2 | 2025 |
Source payment records
|
|||||
| General - Pain Management Normalized: general pain management |
Device | Boston Scientific Corporation | $112.11 | 1 | 2025 |
Source payment records
|
|||||
| OSSDSIGN CATALYST Normalized: ossdsign catalyst |
Device | OssDsign USA Incorporated | $85.92 | 1 | 2025 |
Source payment records
|
|||||
| X-CORE Normalized: x core |
Device | Globus Medical, Inc. | $77.05 | 3 | 2025 |
Source payment records
|
|||||
| ALTERA Normalized: altera |
Device | Globus Medical, Inc. | $68.55 | 2 | 2025 |
Source payment records
|
|||||
| Nalu Neurostimulation System Normalized: nalu neurostimulation system |
Device | Nalu Medical, Inc. | $64.67 | 2 | 2025 |
Source payment records
|
|||||
| MARS Normalized: mars |
Device | Globus Medical, Inc. | $48.47 | 1 | 2025 |
Source payment records
|
|||||
| CANOPY Normalized: canopy |
Device | Globus Medical, Inc. | $41.37 | 1 | 2025 |
Source payment records
|
|||||
| FLOSEAL Normalized: floseal |
Biological | Baxter Healthcare | $38.36 | 2 | 2025 |
Source payment records
|
|||||
| SPRINT PNS System Normalized: sprint pns system |
Device | SPR Therapeutics, Inc | $37.90 | 1 | 2025 |
Source payment records
|
|||||
| XCELL Normalized: xcell |
Device | Bioventus LLC | $32.30 | 1 | 2025 |
Source payment records
|
|||||
| MAXCESS Normalized: maxcess |
Device | Globus Medical, Inc. | $32.03 | 1 | 2025 |
Source payment records
|
|||||
| PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A Normalized: pns freedom 4a permanent neurostimulator receiver kit channel a |
Device | Curonix LLC | $30.41 | 1 | 2025 |
Source payment records
|
|||||
| MAKO Normalized: mako |
Device | Stryker Corporation | $30.31 | 1 | 2025 |
Source payment records
|
|||||
| COALITION AGX Normalized: coalition agx |
Device | Globus Medical, Inc. | $29.90 | 1 | 2025 |
Source payment records
|
|||||
| CAPITOL Normalized: capitol |
Device | Globus Medical, Inc. | $26.70 | 1 | 2025 |
Source payment records
|
|||||
| MAGNETOS Normalized: magnetos |
Device | Kuros Biosciences USA, Inc | $24.33 | 1 | 2025 |
Source payment records
|
|||||
| DUROLANE Normalized: durolane |
Device | Bioventus LLC | $23.68 | 1 | 2025 |
Source payment records
|
|||||
| Evoke Normalized: evoke |
Device | Saluda Medical Americas, Inc. | $19.24 | 1 | 2025 |
Source payment records
|
|||||
| TRUESPAN ORTHOCORD Normalized: truespan orthocord |
Device | DePuy Synthes Sales Inc. | $18.25 | 1 | 2025 |
Source payment records
|
|||||
| EVENITY Normalized: evenity |
Biological | Amgen Inc. | $17.68 | 1 | 2025 |
Source payment records
|
|||||
| INCEPTIV Normalized: inceptiv |
Device | Medtronic, Inc. | $13.62 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Methylprednisolone | Methylprednisolone | 23 | 22 |
| Methocarbamol | Methocarbamol | 15 | 11 |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $319,117.95 · 312 records | Stryker Corporation | 7D Surgical System, ACP, ALTERA, AUGMENT INJECTABLE, CANOPY, CAPITOL, CAPTIVATE, CASCADIA INTERBODY SYSTEM, COALITION AGX, COHERE, CORRIDOR, CREO, Clinical Trial Product, DUROLANE, ES2 SPINAL SYSTEM, EVENITY, EXCELSIUS GPS, Evoke, FLOSEAL, General - Pain Management, I-FACTOR PEPTIDE ENHANCED BONE GRAFT, IFUSE IMPLANT SYSTEM, INCEPTIV, INDEPENDENCE, INTELLIS ADAPTIVESTIM, Intracept, Lattus, MAGNETOS, MAKO, MARS, MAXCESS, MAZOR X SYSTEM, MILD DEVICE KIT, MISCELLANEOUS, MOBI-C PLUG & FIT US, MODULUS, Mariner, N/A, Nalu Neurostimulation System, OMNICURVE, OPTABLATE, OSSDSIGN CATALYST, PCD, PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A, PROCLAIM, PRODISC L, RELINE, SABLE, SIMPLIFY CERVICAL ARTIFICIAL DISC, SPINEJACK, SPINEMAP, SPRINT PNS System, Senza, TRUESPAN ORTHOCORD, VERTAPLEX, VYRSA V1, X-CORE, XCELL, XIA 3 | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error